Gossamer Bio Inc (GOSS)
NASDAQ:GOSS
Holding GOSS?
Track your performance easily

Gossamer Bio (GOSS) Financial Statements

727 Followers

Gossamer Bio Financial Overview

Gossamer Bio's market cap is currently ―. The company's EPS TTM is $-0.4; its P/E ratio is -2.19; Gossamer Bio is scheduled to report earnings on March 21, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 9.48M$ 95.84M---
Gross Profit$ 9.48M$ 95.84M---
EBIT$ -31.93M$ 53.67M$ -38.80M$ -44.91M$ -36.66M
EBITDA$ -30.62M$ 57.98M$ -37.81M$ -43.90M$ -35.58M
Net Income Common Stockholders$ -30.80M$ 49.23M$ -41.93M$ -48.15M$ -40.01M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 327.03M$ 354.49M$ 244.39M$ 296.43M$ 328.89M
Total Assets$ 350.88M$ 373.45M$ 259.36M$ 311.92M$ 347.93M
Total Debt$ 4.59M$ 0.00$ 9.59M$ 12.57M$ 16.24M
Net Debt$ -322.44M$ -354.49M$ -234.81M$ -283.85M$ -312.65M
Total Liabilities$ 296.74M$ 291.92M$ 232.64M$ 249.15M$ 243.31M
Stockholders Equity$ 54.14M$ 81.53M$ 26.69M$ 62.77M$ 104.62M
Cash Flow-
Free Cash Flow$ -32.03M$ 116.35M$ -52.30M$ -33.42M$ -34.46M
Operating Cash Flow$ -32.03M$ 116.35M$ -52.30M$ -33.42M$ -34.49M
Investing Cash Flow$ -26.75M$ -59.11M$ 61.67M$ -14.37M$ -118.26M
Financing Cash Flow$ 281.00K$ -9.21M$ -2.56M$ -2.90M$ 198.50M
Currency in USD

Gossamer Bio Earnings and Revenue History

Gossamer Bio Debt to Assets

Gossamer Bio Cash Flow

Gossamer Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis